Literature DB >> 15164797

Effect of americium-241 alpha-particles on the dose-response of chromosome aberrations in human lymphocytes analysed by fluorescence in situ hybridization.

J F Barquinero1, G Stephan, E Schmid.   

Abstract

PURPOSE: To evaluate by the fluorescent in-situ hybridization (FISH) technique the dose-response and intercellular distribution of alpha-particle-induced chromosome aberrations. In particular, the validity of using the yield of characteristic types of chromosome abnormalities in stable cells as quantitative indicators for retrospective dose reconstruction has been evaluated.
MATERIAL AND METHODS: Monolayers of human peripheral lymphocytes were exposed at doses from 0.02 to 1 Gy to alpha-particles emitted from a source of americium-241. The most probable energy of the alpha-particles entering the cells was 2.7 MeV. FISH painting was performed using DNA probes for chromosomes 2, 4 and 8 in combination with a pan-centromeric probe. In complete first-division cells, identified by harlequin staining, aberrations involving painted target chromosomal material were recorded as well as aberrations involving only unpainted chromosomal material.
RESULTS: In total, the percentage of complex aberrations was about 35% and no dose dependence was observed. When complex-type exchanges were reduced to simple base types, the different cell distributions were clearly over-dispersed, and the linear coefficients of the dose-effect curves for translocations were significantly higher than for dicentrics. For past dose reconstruction, only a few complex aberrations were in stable cells. The linear coefficient obtained for transmissible aberrations in stable cells was more than seven times lower than that obtained in all analysed cells, i.e. including unstable cells.
CONCLUSION: FISH-based analysis of complex rearrangements allows discrimination between partial-body exposures to low-linear energy transfer radiation and high-linear energy transfer exposures. In assessing past or chronic exposure to alpha-particles, the use of a dose-effect curve obtained by FISH-based translocation data, which had not excluded data determined in unstable cells, would underestimate the dose. Insertions are ineffective biomarkers because their frequency is too low.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164797     DOI: 10.1080/09553002310001655430

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  5 in total

1.  Chromosomal aberrations in peripheral lymphocytes of patients treated with radium-224 for ankylosing spondylitis.

Authors:  G Stephan; W U Kampen; D Nosske; H Roos
Journal:  Radiat Environ Biophys       Date:  2005-04-08       Impact factor: 1.925

2.  Chromosome aberrations in workers with exposure to α-particle radiation from internal deposits of plutonium: expectations from in vitro studies and comparisons with workers with predominantly external γ-radiation exposure.

Authors:  Gillian B Curwen; Natalia V Sotnik; Kevin K Cadwell; Tamara V Azizova; Mark A Hill; E Janet Tawn
Journal:  Radiat Environ Biophys       Date:  2015-02-04       Impact factor: 1.925

3.  mFISH analysis of chromosome aberrations in workers occupationally exposed to mixed radiation.

Authors:  Natalia V Sotnik; Sergey V Osovets; Harry Scherthan; Tamara V Azizova
Journal:  Radiat Environ Biophys       Date:  2014-04-09       Impact factor: 1.925

4.  Chromosome aberrations determined by sFISH and G-banding in lymphocytes from workers with internal deposits of plutonium.

Authors:  E Janet Tawn; Gillian B Curwen; Patricia Jonas; Anthony E Riddell; Leanne Hodgson
Journal:  Int J Radiat Biol       Date:  2016-04-04       Impact factor: 2.694

5.  First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness.

Authors:  G A P Cirrone; L Manti; D Margarone; G Petringa; L Giuffrida; A Minopoli; A Picciotto; G Russo; F Cammarata; P Pisciotta; F M Perozziello; F Romano; V Marchese; G Milluzzo; V Scuderi; G Cuttone; G Korn
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.